Who Owns MBX?

MBX Biosciences, Inc. Common Stock — Institutional Ownership & 13F Holdings

$30.11

+1.50 (+5.26%)

Market Cap

$1.1B

Shares Outstanding

33,593,129

Institutional Holders

79

Total Inst. Value

$249.7M

% of Float Held

244.1%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Frazier Life Sciences Management, L.P.$44.2M5,985,347
2ORBIMED ADVISORS LLC$29.5M4,002,887
3NEA Management Company, LLC$26.7M3,614,486
4Deep Track Capital, LP$22.3M3,018,935
5WELLINGTON MANAGEMENT GROUP LLP$19.5M2,638,521
6NVP Associates, LLC$15.8M2,136,335
7DRIEHAUS CAPITAL MANAGEMENT LLC$11.7M1,579,207
8EcoR1 Capital, LLC$9.3M1,259,273
9MPM BioImpact LLC$8.4M1,132,950
10PRICE T ROWE ASSOCIATES INC /MD/$8.1M1,100,916

Biggest Buyers & Sellers This Quarter

Top Buyers

Related Stocks

Frequently Asked Questions

How many institutional investors hold MBX?

As of Q1 2025, 79 institutional investors report holding MBX (MBX Biosciences, Inc. Common Stock) in their 13F filings.

What percentage of MBX Biosciences, Inc. Common Stock is owned by institutions?

Institutional investors hold approximately 244.1% of MBX Biosciences, Inc. Common Stock's float as reported in SEC 13F filings.

Which hedge fund owns the most MBX?

The largest institutional holder of MBX is Frazier Life Sciences Management, L.P. with $44.2M in shares.

Are institutions buying or selling MBX?

This quarter, 28 institutions opened new positions in MBX and 11 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.